Position in VCEL
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$33,626,787
+$7,402,672 QoQ
Shares Held
755,828
-7.3% QoQ
Ownership
1.48%
of shares outstanding
% of Portfolio
0.86%
of 13F equity value
Holder Rank
#18
of 315 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 94%
Shared 0%
None 6%
Common Shares in VCEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Champlain Investment Partners, LLC holds $83,031,252 across 3 Biotechnology names. VCEL ranks #1 (40.5% of the industry book) .
All Filings in VCEL
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $33,626,787 | 755,828 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $26,224,115 | 815,173 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $37,048,780 | 1,028,847 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $31,079,740 | 987,599 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $42,434,732 | 997,291 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $27,387,443 | 613,793 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $34,233,090 | 623,440 | Shares | Sole | 2025-02-13 | |
| No filing history on record for this holder in this stock. | ||||||